Canadian medical cannabis registrations declined after recreational legalization
After Canada legalized recreational cannabis, medical patient registrations declined substantially, but remaining patients increased their purchase sizes and stabilized purchasing frequency.
Quick Facts
What This Study Found
Medical cannabis patient registrations initially increased but slowed after the law passed and decreased after edibles became available. Purchasing frequency decreased but stabilized after edibles arrived. Purchase sizes began increasing after edibles became available.
Key Numbers
Data from 10 Canadian provinces, April 2017-December 2022. Three policy events: law passage (June 2018), recreational sales start (October 2018), edibles/vapes arrival (December 2019).
How They Did This
Linear regressions of interrupted time series models analyzed medical cannabis patient registrations, purchase frequency, and purchase sizes across Canada's 10 provinces from April 2017 to December 2022, testing relationships with three policy milestones.
Why This Research Matters
As more countries consider recreational legalization, understanding how it reshapes existing medical programs helps policymakers plan for transitions that protect patients who rely on medical cannabis access.
The Bigger Picture
The pattern suggests many medical patients were using the medical system as a legal access point and shifted to recreational once available. But the remaining medical patients appear to be genuine therapeutic users who maintained and even increased their consumption.
What This Study Doesn't Tell Us
Administrative data cannot capture reasons for registration changes. Cannot distinguish medical patients who switched to recreational from those who stopped using cannabis entirely. Provincial variation in recreational market rollout not fully captured.
Questions This Raises
- ?Are patients who left the medical system getting appropriate dosing guidance from recreational sources?
- ?Do countries with different medical cannabis frameworks see similar patterns after recreational legalization?
Trust & Context
- Key Stat:
- Medical registrations declined post-legalization
- Evidence Grade:
- Interrupted time series analysis of national data provides strong quasi-experimental evidence, though cannot capture individual-level behavior changes.
- Study Age:
- 2024 analysis of Canadian data from 2017-2022
- Original Title:
- Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.
- Published In:
- American journal of public health, 114(S8), S673-S680 (2024)
- Authors:
- Armstrong, Michael J(5)
- Database ID:
- RTHC-05090
Evidence Hierarchy
Frequently Asked Questions
Did all medical cannabis patients leave after legalization?
No. While registrations declined substantially, the remaining patients actually stabilized their purchasing frequency and increased their purchase sizes, suggesting committed therapeutic users stayed in the medical system.
When did the biggest changes happen?
Registrations began declining after the law passed in June 2018, but the most notable shifts occurred after edibles and vapes became available in December 2019.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05090APA
Armstrong, Michael J. (2024). Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.. American journal of public health, 114(S8), S673-S680. https://doi.org/10.2105/AJPH.2024.307721
MLA
Armstrong, Michael J. "Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.." American journal of public health, 2024. https://doi.org/10.2105/AJPH.2024.307721
RethinkTHC
RethinkTHC Research Database. "Canada's Recreational Cannabis Legalization and Medical Cann..." RTHC-05090. Retrieved from https://rethinkthc.com/research/armstrong-2024-canadas-recreational-cannabis-legalization
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.